1. Home
  2. GSIW vs INBS Comparison

GSIW vs INBS Comparison

Compare GSIW & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSIW
  • INBS
  • Stock Information
  • Founded
  • GSIW 2016
  • INBS 2016
  • Country
  • GSIW Hong Kong
  • INBS United States
  • Employees
  • GSIW N/A
  • INBS N/A
  • Industry
  • GSIW
  • INBS Medical Specialities
  • Sector
  • GSIW
  • INBS Health Care
  • Exchange
  • GSIW Nasdaq
  • INBS Nasdaq
  • Market Cap
  • GSIW 12.3M
  • INBS 12.3M
  • IPO Year
  • GSIW 2023
  • INBS N/A
  • Fundamental
  • Price
  • GSIW $0.51
  • INBS $2.21
  • Analyst Decision
  • GSIW
  • INBS
  • Analyst Count
  • GSIW 0
  • INBS 0
  • Target Price
  • GSIW N/A
  • INBS N/A
  • AVG Volume (30 Days)
  • GSIW 11.8M
  • INBS 394.6K
  • Earning Date
  • GSIW 12-31-2024
  • INBS 02-13-2025
  • Dividend Yield
  • GSIW N/A
  • INBS N/A
  • EPS Growth
  • GSIW N/A
  • INBS N/A
  • EPS
  • GSIW N/A
  • INBS N/A
  • Revenue
  • GSIW $1,313,795.00
  • INBS $3,031,405.00
  • Revenue This Year
  • GSIW N/A
  • INBS $280.88
  • Revenue Next Year
  • GSIW N/A
  • INBS $126.26
  • P/E Ratio
  • GSIW N/A
  • INBS N/A
  • Revenue Growth
  • GSIW N/A
  • INBS 23.21
  • 52 Week Low
  • GSIW $0.43
  • INBS $1.00
  • 52 Week High
  • GSIW $12.98
  • INBS $5.63
  • Technical
  • Relative Strength Index (RSI)
  • GSIW 46.70
  • INBS 57.70
  • Support Level
  • GSIW $0.48
  • INBS $2.04
  • Resistance Level
  • GSIW $0.60
  • INBS $2.75
  • Average True Range (ATR)
  • GSIW 0.12
  • INBS 0.27
  • MACD
  • GSIW 0.00
  • INBS 0.02
  • Stochastic Oscillator
  • GSIW 9.01
  • INBS 51.79

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).

Share on Social Networks: